Home›Companies›Healthcare›Centese

Centese, Inc.

Makes chest drainage systems for care teams treating heart and lung surgery patients.

Updated Nov 10, 2026·Latest SEC filing May 26, 2026·Suggest an edit

About Centese

Centese is a private company based in Omaha, Nebraska. It has reported $15,876,545 raised in three offerings on Form D since November 2023. Its chief executive is Randy Preston.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 21, 2026May 26, 2026$250,000of $5.0M target1$250KEquity, DebtRule 506(b)Form D ↗
May 2, 2025May 12, 2025$525,000of $6.5M target5$105KEquity, DebtRule 506(b)Form D ↗
Nov 3, 2023Nov 20, 2023$15,101,545of $23.1M target50$302KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Total, three offerings$15,876,545

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Centese's Form D filed May 26, 2026.

Randy Preston
Randy Preston
Chief Executive Officer and director
DB
Daniel Burnett
Founder & CEO, THERANOVA MEDICAL DEVICE INCUBATOR, director
DG
Deepak Gangahar
Founder, NEBRASKA HEART INSTITUTE and director
RC
Radu Cautis
Managing Director, MEDTECH VENTURE PARTNERS

Earlier filings also listed Evan Luxon (ceo and director, last listed May 2025) and Alan Chesler (director, last listed Nov 2023).

Sources

  1. SECCentese, Inc. filing history
  2. CompanyAbout Centese